glp 1 fibroids GLP-1 drugs may reduce uterine fibroid risk for women with type 2 diabetes Treating Uterine Fibroids While Preserving

Please note that the other tests mentioned do not directly measure vitamin B12 levels but instead help assess factors related to B12 deficiency or excess

Pajed, L

Lpez-Ferreras L, Eerola K, Shevchouk OT, Richard JE, Nilsson FH, Jansson LE, et al

If gastrointestinal symptoms persist despite adequate hydration and supportive measures, your provider may consider dose reduction, temporary treatment interruption, or prescribing anti-emetic medications such as ondansetron or metoclopramide

The mean weight change from baseline to 12 months in terms of percentage of baseline weight was 5% (95% CI, 6% to 3%)

Hair loss Telogen effluvium, or temporary hair loss related to metabolic stress, is reported by a meaningful subset of patients on GLP-1 therapy